Perfect Holding: Kinarus and Curatis AG Plan Merger, Aim to Reverse Bankruptcy

• Kinarus Therapeutics Holding AG in Liquidation and Curatis AG propose to combine companies and reverse bankruptcy procedures of Kinarus Therapeutics Holding AG in Liquidation
• The Combination Transaction is contingent on court approval, approval by the Extraordinary General Meeting of Kinarus Holding, and SIX Swiss Exchange approval
• Kinarus Holding and Curatis have placed an offer to purchase certain assets, intellectual property, and data relating to KIN001 from the bankruptcy estate of Kinarus AG in Liquidation
• The combined entity will focus on specialty medicine distribution and own drug development activities
• Shareholders and new investors have agreed to invest CHF4.1m via a structured Mandatory Exchangeable Loan Note
• The new Board of Directors will consist of the founders of Curatis, Günter Graubach and Roland Rutschmann, as well as Marian Borovsky and Silvio Inderbitzin